Concepedia

Breakthrough Therapy Strategy

Breakthrough Therapy Strategy is a regulatory development approach within the domain of pharmaceutical policy that is distinguished by its intent to expedite the approval process for therapies addressing serious or life-threatening conditions based on preliminary clinical evidence indicating substantial improvement over existing treatments.

94

Publications

9K

Citations

477

Authors

229

Institutions

Publications per year

2017–2026

49

Parents

Publications

94

A New Initiative on Precision Medicine

Francis S. Collins, Harold Varmus · New England Journal of Medicine · 2015 · 5.2K citations · Full text

, , +15

Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015.

Temitope Folaranmi, Lorry G. Rubin, Stacey W. Martin et al. · PubMed · 2015 · 204 citations

, , +11

EMDR: the breakthrough therapy for overcoming anxiety, stress, and trauma

Choice Reviews Online · 1997 · 199 citations

, , +17

Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer

Donald P. McDonnell, Suzanne E. Wardell, John D. Norris · Journal of Medicinal Chemistry · 2015 · 170 citations · Full text

, , +17

Biodegradable Nanoprodrugs: “Delivering” ROS to Cancer Cells for Molecular Dynamic Therapy

Zhongmin Tang, Yanyan Liu, Dalong Ni et al. · Advanced Materials · 2019 · 161 citations

, , +17

1–5 of 94

Authors

477

  1. AS
    Aaron S. Kesselheim

    Brigham and Women's Hospital, United States

    6 publications · 437 citations

    6

    h-index

  2. JJ
    Jonathan J. Darrow

    Brigham and Women's Hospital, United States

    5 publications · 404 citations

    5

    h-index

  3. TJ
    Thomas J. Hwang

    Brigham and Women's Hospital, United States

    4 publications · 261 citations

    4

    h-index

  4. WB
    Wenbo Bu

    Shanghai Institute of Ceramics, China

    2 publications · 211 citations

    2

    h-index

  5. DN
    Dalong Ni

    Chinese Academy of Sciences, China

    2 publications · 211 citations

    2

    h-index

1–5 of 477

Institutions

229

  1. Brigham and Women's Hospital

    Boston, United States

    5 h-index

    14 publications

    969 citations

  2. Harvard University

    Cambridge, United States

    4 h-index

    7 publications

    594 citations

  3. Imperial College London

    London, United Kingdom

    3 h-index

    6 publications

    291 citations

  4. Tianjin Medical University Cancer Institute and Hospital

    Tianjin, China

    3 h-index

    23 publications

    1.1K citations

  5. Pfizer (United States)

    New York, United States

    3 h-index

    11 publications

    464 citations

  6. Peking Union Medical College Hospital

    Beijing, China

    3 h-index

    4 publications

    98 citations

  7. Chinese Academy of Medical Sciences & Peking Union Medical College

    Beijing, China

    3 h-index

    6 publications

    170 citations

  8. United States Food and Drug Administration

    Silver Spring, United States

    2 h-index

    7 publications

    445 citations

1–8 of 229

Venues

  1. PubMed

    Repository · 6 publications · 288 citations

    6

    h-index

  2. New England Journal of Medicine

    NEJM · 5 publications · 5.4K citations

    5

    h-index

  3. Clinical Pharmacology & Therapeutics

    CPT · 4 publications · 115 citations

    4

    h-index

  4. Drugs of today

    3 publications · 56 citations

    3

    h-index

  5. Social Science & Medicine

    3 publications · 157 citations

    3

    h-index

1–5